HM13 and Hypertension: Therefore, our follow-up study is needed to confirm the relationship among SPP, prognosis, and efficacy of the risk classification in hemodialysis patients including other confounding: a measure of hypertension, number of hypertensive medications, a measure of cholesterol and diabetes management, and calcium, phosphate, and intact PTH levels.